Prevention of postpartum hemorrhage in moderate and high‐risk patients: Addition of prophylactic misoprostol.
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70541 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Ashlesha K Dayal und 6 weiteren Autor:innen. Beteiligte Einrichtung: New York-Presbyterian Queens, Flushing, New York, USA. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, Misoprostol, Oxytocin, Oxytocics. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objective
We sought to evaluate the impact of a prospective change in practice to dual pharmacologic prophylaxis with oxytocin and misoprostol for patients at moderate or high risk for postpartum hemorrhage (PPH) based on validated hemorrhage risk assessments on PPH rates, quantitative blood loss (QBL) amounts, and morbidities.
Methods
A quality improvement effort was undertaken with the addition of sublingual misoprostol prophylaxis immediately after birth for patients with moderate or high risk for hemorrhage during pre‐birth PPH risk assessment, 200 μg for moderate and 400 μg for high risk. “Oxytocin only” prophylaxis was administered June 2021 to April 2022 and “dual agent” prophylaxis was given April 2022 to April 2023. Inclusion criteria: deliveries ≥20 weeks' gestation with moderate or high‐risk pre‐birth PPH risk assessment. Exclusion criteria: missing QBL, gestational age
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New York-Presbyterian Queens, Flushing, New York, USA.
- Weill Cornell Medicine, New York, New York, USA.
- Department of Obstetrics and Gynecology, Vagelos College of Physician and Surgeons, Columbia University, New York, New York, USA.
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
- NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
Zitieren
APA
Dayal, A. K., Skupski, D. W., Chan-Akeley, R., Lu, L., Bejerano, S., Velagala, D., & Goffman, D. (2025). Prevention of postpartum hemorrhage in moderate and high‐risk patients: Addition of prophylactic misoprostol. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70541
Vancouver
Dayal AK, Skupski DW, Chan-Akeley R, Lu L, Bejerano S, Velagala D, et al. Prevention of postpartum hemorrhage in moderate and high‐risk patients: Addition of prophylactic misoprostol. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70541
BibTeX
@article{Dayal2025,
author = {Dayal, Ashlesha K and Skupski, Daniel W and Chan-Akeley, Rosalyn and Lu, Liping and Bejerano, Shai and Velagala, Dinakar and Goffman, Dena},
title = {Prevention of postpartum hemorrhage in moderate and high‐risk patients: Addition of prophylactic misoprostol},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70541}
}
EUVIMED